학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 884건 | 목록
1~20
Academic Journal
2 Kazan U. L. Rev. 55 (2017) / Kazan University Law Review, Vol. 2, Issue 1 (Spring 2017), pp. 55-69
Academic Journal
Academic Journal
Environmental Monitoring and Assessment: An International Journal Devoted to Progress in the Use of Monitoring Data in Assessing Environmental Risks to Man and the Environment. December 1982 1(4):373-382
Academic Journal
Academic Journal
Zampaoglou, Evgenia; Boureka, Eirini; Gounari, Evdoxia; Liasidi, Polyxeni-Natalia; Kalogiannidis, Ioannis; Tsimtsiou, Zoi; Haidich, Anna-Bettina; Tsakiridis, Ioannis; Dagklis, Themistoklis
Book
Academic Journal
Josephson, Colin B.; Beniczky, Sandor; Denaxas, Spiros; Ikeda, Akio; Jehi, Lara; Mwesige, Angelina Kakooza; Jette, Nathalie; Jones, Gabriel Davis; Ryvlin, Philippe; Sen, Arjune; Triki, Chahnez Charfi; Waters, Gabriella; Guekht, Alla; Cross, J. Helen
Report
Pharmaceutical Society of the Vaud Canton ('SVPh: Société Vaudoise de pharmacie'); Canton of Vaud ('État de Vaud')
Feasibility Study of the Medication Review With Follow up Service for Patients With Polypharmacy in Swiss Community Pharmacies
Guignard E, Bugnon O. Pharmaceutical care incommunity pharmacies: practice and research in Switzerland. Ann Pharmacother. 2006 Mar;40(3):512-7. doi: 10.1345/aph.1G199. Epub 2006 Feb 7.
Hersberger KE, Messerli M. Development of Clinical Pharmacy in Switzerland: Involvement ofCommunity Pharmacists in Care for Older Patients. Drugs Aging. 2016 Mar;33(3):205-11. doi: 10.1007/s40266-016-0353-6.
Krahenbuhl JM, Kremer B, Guignard B, Bugnon O. Practical evaluation of the drug-related problem management process in Swisscommunity pharmacies. Pharm World Sci. 2008 Dec;30(6):777-86. doi: 10.1007/s11096-008-9217-4. Epub 2008 Apr 6.
Lim XY, Yeo QQ, Kng GLL, Chung WL, Yap KZ. Validation of a Drug-Related Problem Classification System for the Intermediate and Long-Term Care Setting in Singapore. Pharmacy (Basel). 2018 Oct 3;6(4):109. doi: 10.3390/pharmacy6040109.
Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current Situation of Medication Adherence in Hypertension. Front Pharmacol. 2017 Mar 1;8:100. doi: 10.3389/fphar.2017.00100. eCollection 2017.
Perez-Jover V, Mira JJ, Carratala-Munuera C, Gil-Guillen VF, Basora J, Lopez-Pineda A, Orozco-Beltran D. Inappropriate Use of Medication by Elderly, Polymedicated, or Multipathological Patients with Chronic Diseases. Int J Environ Res Public Health. 2018 Feb 10;15(2):310. doi: 10.3390/ijerph15020310.
Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, Carey DL. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2004 Apr;57(4):513-21. doi: 10.1046/j.1365-2125.2003.02029.x.
Hanlon JT, Lindblad CI, Gray SL. Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes incommunity -based older adults? Am J Geriatr Pharmacother. 2004 Mar;2(1):3-13. doi: 10.1016/s1543-5946(04)90002-5.
Tasaka Y, Tanaka A, Yasunaga D, Asakawa T, Araki H, Tanaka M. Potential drug-related problems detected by routine pharmaceutical interventions: safety and economic contributions made by hospital pharmacists in Japan. J Pharm Health Care Sci. 2018 Dec 13;4:33. doi: 10.1186/s40780-018-0125-z. eCollection 2018.
Messerli M, Blozik E, Vriends N, Hersberger KE. Impact of acommunity pharmacist-led medication review on medicines use in patients on polypharmacy--a prospective randomised controlled trial. BMC Health Serv Res. 2016 Apr 23;16:145. doi: 10.1186/s12913-016-1384-8.
Griese-Mammen N, Hersberger KE, Messerli M, Leikola S, Horvat N, van Mil JWF, Kos M. PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 2018 Oct;40(5):1199-1208. doi: 10.1007/s11096-018-0696-7. Epub 2018 Aug 2.
Messerli M, Vriends N, Hersberger KE. Humanistic outcomes and patient acceptance of the pharmacist-led medication review "Polymedication Check" in primary care in Switzerland: a prospective randomized controlled trial. Patient Prefer Adherence. 2018 Jun 19;12:1071-1078. doi: 10.2147/PPA.S160789. eCollection 2018.
Rutter P. Role ofcommunity pharmacists in patients' self-care and self-medication. Integr Pharm Res Pract. 2015 Jun 24;4:57-65. doi: 10.2147/IPRP.S70403. eCollection 2015.
Cooper RJ. Over-the-counter medicine abuse - a review of the literature. J Subst Use. 2013 Apr;18(2):82-107. doi: 10.3109/14659891.2011.615002. Epub 2011 Oct 3.
Maes KA, Hersberger KE, Lampert ML. Pharmaceutical interventions on prescribed medicines incommunity pharmacies: focus on patient-reported problems. Int J Clin Pharm. 2018 Apr;40(2):335-340. doi: 10.1007/s11096-018-0595-y. Epub 2018 Feb 5.
Nathan A, Goodyer L, Lovejoy A, Rashid A. 'Brown bag' medication reviews as a means of optimizing patients' use of medication and of identifying potential clinical problems. Fam Pract. 1999 Jun;16(3):278-82. doi: 10.1093/fampra/16.3.278.
O'Connell MB, Chang F, Tocco A, Mills ME, Hwang JM, Garwood CL, Khreizat HS, Gupta NS. Drug-Related-Problem Outcomes and Program Satisfaction from a Comprehensive Brown Bag Medication Review. J Am Geriatr Soc. 2015 Sep;63(9):1900-5. doi: 10.1111/jgs.13597. Epub 2015 Aug 27.
Sarzynski EM, Luz CC, Rios-Bedoya CF, Zhou S. Considerations for using the 'brown bag' strategy to reconcile medications during routine outpatient office visits. Qual Prim Care. 2014;22(4):177-87.
Ocampo CC, Garcia-Cardenas V, Martinez-Martinez F, Benrimoj SI, Amariles P, Gastelurrutia MA. Implementation of medication review with follow-up in a Spanishcommunity pharmacy and its achieved outcomes. Int J Clin Pharm. 2015 Oct;37(5):931-40. doi: 10.1007/s11096-015-0145-9. Epub 2015 Jun 4.
Varas-Doval R, Gastelurrutia MA, Benrimoj SI, Garcia-Cardenas V, Saez-Benito L, Martinez-Martinez F. Clinical impact of a pharmacist-led medication review with follow up for aged polypharmacy patients: A cluster randomized controlled trial. Pharm Pract (Granada). 2020 Oct-Dec;18(4):2133. doi: 10.18549/PharmPract.2020.4.2133. Epub 2020 Oct 21.
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.
de Barra M, Scott C, Johnston M, De Bruin M, Scott N, Matheson C, Bond C, Watson M. Do pharmacy intervention reports adequately describe their interventions? A template for intervention description and replication analysis of reports included in a systematic review. BMJ Open. 2019 Dec 19;9(12):e025511. doi: 10.1136/bmjopen-2018-025511.
McPherson ML, Smith SW, Powers A, Zuckerman IH. Association between diabetes patients' knowledge about medications and their blood glucose control. Res Social Adm Pharm. 2008 Mar;4(1):37-45. doi: 10.1016/j.sapharm.2007.01.002.
Liu-Seifert H, Zhang S, D'Souza D, Skljarevski V. A closer look at the baseline-observation-carried-forward (BOCF). Patient Prefer Adherence. 2010 Feb 4;4:11-6. doi: 10.2147/ppa.s8135.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.
Okuyan B, Sancar M, Izzettin FV. Assessment of medication knowledge and adherence among patients under oral chronic medication treatment incommunity pharmacy settings. Pharmacoepidemiol Drug Saf. 2013 Feb;22(2):209-14. doi: 10.1002/pds.3275. Epub 2012 Apr 18.
Jokanovic N, Tan EC, Sudhakaran S, Kirkpatrick CM, Dooley MJ, Ryan-Atwood TE, Bell JS. Pharmacist-led medication review incommunity settings: An overview of systematic reviews. Res Social Adm Pharm. 2017 Jul-Aug;13(4):661-685. doi: 10.1016/j.sapharm.2016.08.005. Epub 2016 Aug 28.
Malet-Larrea A, Goyenechea E, Garcia-Cardenas V, Calvo B, Arteche JM, Aranegui P, Zubeldia JJ, Gastelurrutia MA, Martinez-Martinez F, Benrimoj SI. The impact of a medication review with follow-up service on hospital admissions in aged polypharmacy patients. Br J Clin Pharmacol. 2016 Sep;82(3):831-8. doi: 10.1111/bcp.13012. Epub 2016 Jun 9.
Varas-Doval R, Gastelurrutia MA, Benrimoj SI, Zarzuelo MJ, Garcia-Cardenas V, Perez-Escamilla B, Martinez-Martinez F. Evaluating an implementation programme for medication review with follow-up incommunity pharmacy using a hybrid effectiveness study design: translating evidence into practice. BMJ Open. 2020 Sep 29;10(9):e036669. doi: 10.1136/bmjopen-2019-036669.
Noain A, Garcia-Cardenas V, Gastelurrutia MA, Malet-Larrea A, Martinez-Martinez F, Sabater-Hernandez D, Benrimoj SI. Cost analysis for the implementation of a medication review with follow-up service in Spain. Int J Clin Pharm. 2017 Aug;39(4):750-758. doi: 10.1007/s11096-017-0454-2. Epub 2017 Apr 22.
Jodar-Sanchez F, Malet-Larrea A, Martin JJ, Garcia-Mochon L, Lopez Del Amo MP, Martinez-Martinez F, Gastelurrutia-Garralda MA, Garcia-Cardenas V, Sabater-Hernandez D, Saez-Benito L, Benrimoj SI. Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy incommunity pharmacies in Spain: the conSIGUE program. Pharmacoeconomics. 2015 Jun;33(6):599-610. doi: 10.1007/s40273-015-0270-2.
Ahumada-Canale A, Vargas C, Martinez-Mardones F, Plaza-Plaza JC, Benrimoj S, Garcia-Cardenas V. Cost-utility analysis of medication review with follow-up for cardiovascular outcomes: A microsimulation model. Health Policy. 2021 Nov;125(11):1406-1414. doi: 10.1016/j.healthpol.2021.09.004. Epub 2021 Sep 16.
Stratton SJ. Quasi-Experimental Design (Pre-Test and Post-Test Studies) in Prehospital and Disaster Research. Prehosp Disaster Med. 2019 Dec;34(6):573-574. doi: 10.1017/S1049023X19005053. No abstract available.
Amador-Fernandez N, Escaith M, Simi E, Quintana-Barcena P, Berger J. Evaluation of an enhanced service for medication review with follow up in Swisscommunity pharmacies: Pre-post study protocol. PLoS One. 2023 Oct 17;18(10):e0292037. doi: 10.1371/journal.pone.0292037. eCollection 2023.
Guignard E, Bugnon O. Pharmaceutical care in
Hersberger KE, Messerli M. Development of Clinical Pharmacy in Switzerland: Involvement of
Krahenbuhl JM, Kremer B, Guignard B, Bugnon O. Practical evaluation of the drug-related problem management process in Swiss
Lim XY, Yeo QQ, Kng GLL, Chung WL, Yap KZ. Validation of a Drug-Related Problem Classification System for the Intermediate and Long-Term Care Setting in Singapore. Pharmacy (Basel). 2018 Oct 3;6(4):109. doi: 10.3390/pharmacy6040109.
Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current Situation of Medication Adherence in Hypertension. Front Pharmacol. 2017 Mar 1;8:100. doi: 10.3389/fphar.2017.00100. eCollection 2017.
Perez-Jover V, Mira JJ, Carratala-Munuera C, Gil-Guillen VF, Basora J, Lopez-Pineda A, Orozco-Beltran D. Inappropriate Use of Medication by Elderly, Polymedicated, or Multipathological Patients with Chronic Diseases. Int J Environ Res Public Health. 2018 Feb 10;15(2):310. doi: 10.3390/ijerph15020310.
Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, Carey DL. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2004 Apr;57(4):513-21. doi: 10.1046/j.1365-2125.2003.02029.x.
Hanlon JT, Lindblad CI, Gray SL. Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in
Tasaka Y, Tanaka A, Yasunaga D, Asakawa T, Araki H, Tanaka M. Potential drug-related problems detected by routine pharmaceutical interventions: safety and economic contributions made by hospital pharmacists in Japan. J Pharm Health Care Sci. 2018 Dec 13;4:33. doi: 10.1186/s40780-018-0125-z. eCollection 2018.
Messerli M, Blozik E, Vriends N, Hersberger KE. Impact of a
Griese-Mammen N, Hersberger KE, Messerli M, Leikola S, Horvat N, van Mil JWF, Kos M. PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 2018 Oct;40(5):1199-1208. doi: 10.1007/s11096-018-0696-7. Epub 2018 Aug 2.
Messerli M, Vriends N, Hersberger KE. Humanistic outcomes and patient acceptance of the pharmacist-led medication review "Polymedication Check" in primary care in Switzerland: a prospective randomized controlled trial. Patient Prefer Adherence. 2018 Jun 19;12:1071-1078. doi: 10.2147/PPA.S160789. eCollection 2018.
Rutter P. Role of
Cooper RJ. Over-the-counter medicine abuse - a review of the literature. J Subst Use. 2013 Apr;18(2):82-107. doi: 10.3109/14659891.2011.615002. Epub 2011 Oct 3.
Maes KA, Hersberger KE, Lampert ML. Pharmaceutical interventions on prescribed medicines in
Nathan A, Goodyer L, Lovejoy A, Rashid A. 'Brown bag' medication reviews as a means of optimizing patients' use of medication and of identifying potential clinical problems. Fam Pract. 1999 Jun;16(3):278-82. doi: 10.1093/fampra/16.3.278.
O'Connell MB, Chang F, Tocco A, Mills ME, Hwang JM, Garwood CL, Khreizat HS, Gupta NS. Drug-Related-Problem Outcomes and Program Satisfaction from a Comprehensive Brown Bag Medication Review. J Am Geriatr Soc. 2015 Sep;63(9):1900-5. doi: 10.1111/jgs.13597. Epub 2015 Aug 27.
Sarzynski EM, Luz CC, Rios-Bedoya CF, Zhou S. Considerations for using the 'brown bag' strategy to reconcile medications during routine outpatient office visits. Qual Prim Care. 2014;22(4):177-87.
Ocampo CC, Garcia-Cardenas V, Martinez-Martinez F, Benrimoj SI, Amariles P, Gastelurrutia MA. Implementation of medication review with follow-up in a Spanish
Varas-Doval R, Gastelurrutia MA, Benrimoj SI, Garcia-Cardenas V, Saez-Benito L, Martinez-Martinez F. Clinical impact of a pharmacist-led medication review with follow up for aged polypharmacy patients: A cluster randomized controlled trial. Pharm Pract (Granada). 2020 Oct-Dec;18(4):2133. doi: 10.18549/PharmPract.2020.4.2133. Epub 2020 Oct 21.
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.
de Barra M, Scott C, Johnston M, De Bruin M, Scott N, Matheson C, Bond C, Watson M. Do pharmacy intervention reports adequately describe their interventions? A template for intervention description and replication analysis of reports included in a systematic review. BMJ Open. 2019 Dec 19;9(12):e025511. doi: 10.1136/bmjopen-2018-025511.
McPherson ML, Smith SW, Powers A, Zuckerman IH. Association between diabetes patients' knowledge about medications and their blood glucose control. Res Social Adm Pharm. 2008 Mar;4(1):37-45. doi: 10.1016/j.sapharm.2007.01.002.
Liu-Seifert H, Zhang S, D'Souza D, Skljarevski V. A closer look at the baseline-observation-carried-forward (BOCF). Patient Prefer Adherence. 2010 Feb 4;4:11-6. doi: 10.2147/ppa.s8135.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.
Okuyan B, Sancar M, Izzettin FV. Assessment of medication knowledge and adherence among patients under oral chronic medication treatment in
Jokanovic N, Tan EC, Sudhakaran S, Kirkpatrick CM, Dooley MJ, Ryan-Atwood TE, Bell JS. Pharmacist-led medication review in
Malet-Larrea A, Goyenechea E, Garcia-Cardenas V, Calvo B, Arteche JM, Aranegui P, Zubeldia JJ, Gastelurrutia MA, Martinez-Martinez F, Benrimoj SI. The impact of a medication review with follow-up service on hospital admissions in aged polypharmacy patients. Br J Clin Pharmacol. 2016 Sep;82(3):831-8. doi: 10.1111/bcp.13012. Epub 2016 Jun 9.
Varas-Doval R, Gastelurrutia MA, Benrimoj SI, Zarzuelo MJ, Garcia-Cardenas V, Perez-Escamilla B, Martinez-Martinez F. Evaluating an implementation programme for medication review with follow-up in
Noain A, Garcia-Cardenas V, Gastelurrutia MA, Malet-Larrea A, Martinez-Martinez F, Sabater-Hernandez D, Benrimoj SI. Cost analysis for the implementation of a medication review with follow-up service in Spain. Int J Clin Pharm. 2017 Aug;39(4):750-758. doi: 10.1007/s11096-017-0454-2. Epub 2017 Apr 22.
Jodar-Sanchez F, Malet-Larrea A, Martin JJ, Garcia-Mochon L, Lopez Del Amo MP, Martinez-Martinez F, Gastelurrutia-Garralda MA, Garcia-Cardenas V, Sabater-Hernandez D, Saez-Benito L, Benrimoj SI. Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in
Ahumada-Canale A, Vargas C, Martinez-Mardones F, Plaza-Plaza JC, Benrimoj S, Garcia-Cardenas V. Cost-utility analysis of medication review with follow-up for cardiovascular outcomes: A microsimulation model. Health Policy. 2021 Nov;125(11):1406-1414. doi: 10.1016/j.healthpol.2021.09.004. Epub 2021 Sep 16.
Stratton SJ. Quasi-Experimental Design (Pre-Test and Post-Test Studies) in Prehospital and Disaster Research. Prehosp Disaster Med. 2019 Dec;34(6):573-574. doi: 10.1017/S1049023X19005053. No abstract available.
Amador-Fernandez N, Escaith M, Simi E, Quintana-Barcena P, Berger J. Evaluation of an enhanced service for medication review with follow up in Swiss
Report
Pilot Study on Enhancing Mobility and Accessibility for Visually Impaired Individuals in Barcelona Using Navigation With XR Technology and 5G
Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844-851. Peters D, Bengtsson B, Heijl A. Lifetime risk of blindness in open-angle glaucoma. Am J Ophthalmol 2013; 156: 724-730. Bourne RRA, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health 2017; 5: e888-e897. Bourne R, Price H, Taylor H, et al. New systematic review methodology for visual impairment and blindness for the 2010 Global Burden of Disease study. Ophthalmic Epidemiol 2013; 20: 33-39. Burton MJ, Ramke J, Marques AP, et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. Lancet Glob Health 2021; 9: e489-e551. Wang MY, Rousseau J, Boisjoly H, et al. Activity limitation due to a fear of falling in older adults with eye disease. Invest Ophthalmol Vis Sci 2012; 53: 7967-7972. Kempen GIJM, Ballemans J, Ranchor AV, et al. The impact of low vision on activities of daily living, symptoms of depression, feelings of anxiety and social support incommunity -living older adults seeking vision rehabilitation services. Qual Life Res 2012; 21: 1405-1411. Wang MY, Rousseau J, Boisjoly H, et al. Activity limitation due to a fear of falling in older adults with eye disease. Invest Ophthalmol Vis Sci 2012; 53: 7967-7972. Ong SR, Crowston JG, Loprinzi PD, et al. Physical activity, visual impairment, and eye disease. Eye 2018; 32: 1296-1303. Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14. An index of functional impairment in patients with cataract. Arch Ophth
Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844-851. Peters D, Bengtsson B, Heijl A. Lifetime risk of blindness in open-angle glaucoma. Am J Ophthalmol 2013; 156: 724-730. Bourne RRA, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health 2017; 5: e888-e897. Bourne R, Price H, Taylor H, et al. New systematic review methodology for visual impairment and blindness for the 2010 Global Burden of Disease study. Ophthalmic Epidemiol 2013; 20: 33-39. Burton MJ, Ramke J, Marques AP, et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. Lancet Glob Health 2021; 9: e489-e551. Wang MY, Rousseau J, Boisjoly H, et al. Activity limitation due to a fear of falling in older adults with eye disease. Invest Ophthalmol Vis Sci 2012; 53: 7967-7972. Kempen GIJM, Ballemans J, Ranchor AV, et al. The impact of low vision on activities of daily living, symptoms of depression, feelings of anxiety and social support in
Academic Journal
Bohîlțea, Roxana Elena; Furtunescu, Florentina; Grigoriu, Corina; Mitran, Mihai; Ducu, Ioniță; Mihai, Bianca Margareta; Berceanu, Costin
검색 결과 제한하기
제한된 항목
[검색어] Guide to the Council of the European Communities
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어